发明授权
US06509340B1 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands
失效
酰胺和尿素衍生物作为5-HT再摄取抑制剂和5-HT1B / 1D配体
- 专利标题: Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands
- 专利标题(中): 酰胺和尿素衍生物作为5-HT再摄取抑制剂和5-HT1B / 1D配体
-
申请号: US09868840申请日: 2001-10-03
-
公开(公告)号: US06509340B1公开(公告)日: 2003-01-21
- 发明人: Christoph Van Amsterdam , Hartmut Greiner , Henning Boettcher , Gerd Bartoszyk , Juergen Harting , Lisa Matzen , Wilfried Rautenberg
- 申请人: Christoph Van Amsterdam , Hartmut Greiner , Henning Boettcher , Gerd Bartoszyk , Juergen Harting , Lisa Matzen , Wilfried Rautenberg
- 优先权: DE19756036 19971217
- 主分类号: A61K3140
- IPC分类号: A61K3140
摘要:
Amide and urea derivatives of the formula I R1—(CH2)n—(Y)q—(Z)r—CO—NH—R2 (I) in which R1, n, Y, q, Z, r and R2 have the meanings indicated in Claim 1, are potent 5-HT1B/1D antagonists and exhibit 5-HT reuptake-inhibiting actions and are suitable for the treatment and prophylaxis of anxiety states, depressions, schizophrenia, compulsive ideas, tardive dyskinesias, learning disorders, age-dependent memory disorders, for positively affecting obsessive-compulsive behaviour (OCD), and also for the treatment and for the control of the sequelae of cerebral infarcts such as stroke and cerebral ischaemias.
信息查询